STERIS plc logo
STESTERIS plc

Debt to Assets Ratio: 19.44%

popular:market cap|pe ratio|revenue|price history|total return

Is the debt to assets ratio high or low?

The debt to assets ratio of 19.44% is 27% below its 5-year average of 26.75%, near the low end of its 5-year range (19.39%–32.21%).

As of Friday, June 26, 2026. 3.00% below its 12-month average of 20.04%.

Debt/Equity|Total Debt|Total Assets|Interest Coverage|All Metrics
Debt to Assets

STE Debt to Assets Ratio

19.44%

Reported quarterly debt to assets ratio; no daily interpolation.

-38.72% 5Y
STE Debt to Assets Ratio

STE Average Debt to Assets Ratio Chart

STE Debt to Assets Ratio

STE Current vs Average Debt to Assets Ratio Chart

STE Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

19.44%

DEBT TO ASSETS RATIO AVG TTM

20.04%

DEBT TO ASSETS RATIO AVG 3Y

24.91%

DEBT TO ASSETS RATIO AVG 5Y

26.75%

DEBT TO ASSETS RATIO AVG 10Y

26.59%

DEBT TO ASSETS RATIO AVG 15Y

26.15%

DEBT TO ASSETS RATIO AVG 20Y

23.34%

CURRENT VS TTM AVG

-3.00%

CURRENT VS 3Y AVG

-21.97%

CURRENT VS 5Y AVG

-27.33%

CURRENT VS 10Y AVG

-26.90%

CURRENT VS 15Y AVG

-25.66%

CURRENT VS 20Y AVG

-16.71%

STE Competitors' Debt to Assets Ratio

NAMEMARKET CAPDEBT TO ASSETS RATIOTTM3Y5Y
STERIS plc (STE)$20.52B19.44%20.04%24.91%26.75%
Incyte Corporation (INCY)vs ›$21.48B0.01%N/AN/AN/A
Labcorp Holdings Inc. (LH)vs ›$21.83B0.39%N/AN/AN/A
Viatris Inc. (VTRS)vs ›$18.71B0.40%N/AN/AN/A
BioNTech SE (BNTX)vs ›$22.76B0.01%N/AN/AN/A
Quest Diagnostics Incorporated (DGX)vs ›$22.83B0.43%N/AN/AN/A
United Therapeutics Corporation (UTHR)vs ›$23.07B0.00%N/AN/AN/A
Zimmer Biomet Holdings, Inc. (ZBH)vs ›$17.60B0.33%N/AN/AN/A
Moderna, Inc. (MRNA)vs ›$23.71B0.16%N/AN/AN/A
Hologic, Inc. (HOLX)vs ›$16.97B0.29%N/AN/AN/A

Leverage Ratios Comparison

Debt/Assets

19.4%

Debt/Equity

0.29

Current Ratio

2.09

Interest Coverage

18.1x

Formula: Debt/Assets = Total Debt / Total Assets × 100

Debt/Assets vs Debt/Equity:

  • Debt/Assets: Shows % of assets funded by creditors (bounded 0-100%)
  • Debt/Equity: Shows debt relative to shareholder investment (can exceed 100%)
  • Both measure leverage but from different perspectives

Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.

Debt to Assets Ratio Formula & Definition

Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Debt to Assets Ratio FAQ

What is the debt to assets ratio for STERIS plc (STE)?
The debt to assets ratio for STE stock is 19.44%.
Is STERIS plc's debt to assets ratio high or low?
The debt to assets ratio of 19.44% is 27% below its 5-year average of 26.75%, near the low end of its 5-year range (19.39%–32.21%).
What is the TTM average debt to assets ratio for STERIS plc (STE)?
The TTM average debt to assets ratio for STE stock is 20.04%.
What is the 3Y average debt to assets ratio for STERIS plc (STE)?
The 3Y average debt to assets ratio for STE stock is 24.91%.
What is the 5Y average debt to assets ratio for STERIS plc (STE)?
The 5Y average debt to assets ratio for STE stock is 26.75%.
What is the 10Y average debt to assets ratio for STERIS plc (STE)?
The 10Y average debt to assets ratio for STE stock is 26.59%.
What is the 15Y average debt to assets ratio for STERIS plc (STE)?
The 15Y average debt to assets ratio for STE stock is 26.15%.
What is the 20Y average debt to assets ratio for STERIS plc (STE)?
The 20Y average debt to assets ratio for STE stock is 23.34%.

STE Debt to Assets Ratio History

DATEDEBT TO ASSETS RATIO
2026-03-3119.44%
2025-12-3119.39%
2025-09-3019.77%
2025-06-3019.88%
2025-03-3121.71%
2024-12-3123.18%
2024-09-3023.43%
2024-06-3024.58%
2024-03-3130.58%
2023-12-3130.69%
2023-09-3032.21%
2023-06-3028.96%
2023-03-3130.02%
2022-12-3130.12%
2022-09-3030.53%
2022-06-3028.45%
2022-03-3128.71%
2021-12-3129.93%
2021-09-3031.01%
2021-06-3031.72%
2021-03-3127.42%
2020-12-3128.34%
2020-09-3021.23%
2020-06-3022.43%
2020-03-3123.61%
2019-12-3123.62%
2019-09-3025.14%
2019-06-3025.48%
2019-03-3123.32%
2018-12-3124.89%
2018-09-3025.25%
2018-06-3026.13%
2018-03-3125.31%
2017-12-3127.54%
2017-09-3028.23%
2017-06-3029.60%
2017-03-3130.02%
2016-12-3130.84%
2016-09-3028.87%
2016-06-3029.32%
2016-03-3129.32%
2015-12-3130.64%
2015-09-3035.94%
2015-06-3031.45%
2015-03-3129.61%
2014-12-3130.12%
2014-09-3030.58%
2014-06-3032.10%
2014-03-3126.15%
2013-12-3126.70%
2013-09-3028.43%
2013-06-3028.95%
2013-03-3127.95%
2012-12-3129.51%
2012-09-3026.60%
2012-06-3014.96%
2012-03-3114.94%
2011-12-3115.26%
2011-09-3015.30%
2011-06-3014.82%
2011-03-3114.72%
2010-12-3115.53%
2010-09-3016.22%
2010-06-3016.59%
2010-03-3116.96%
2009-12-3123.93%
2009-09-3016.62%
2009-06-3017.28%
2009-03-3117.26%
2008-12-3117.60%
2008-09-3019.68%
2008-06-3014.68%
2008-03-3114.52%
2007-12-3111.13%
2007-09-3010.43%
2007-06-309.31%
2007-03-318.40%
2006-12-3110.82%
2006-09-3012.75%
2006-06-3015.86%
2006-03-319.78%
2005-12-319.52%
2005-09-309.40%
2005-06-3011.28%
2005-03-319.21%
2004-12-319.44%
2004-09-3010.19%
2004-06-3010.11%
2004-03-3110.59%
2003-12-3111.39%
2003-09-3010.84%
2003-06-3012.18%
2003-03-316.89%
2002-12-3110.36%
2002-09-3012.10%
2002-06-3012.77%

Related Metrics

Debt/EquityTotal DebtTotal AssetsInterest CoverageAll Metrics

About STERIS plc

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Mentor, OH
17,840 employees
www.steris.com
Healthcare / Medical - Equipment & Services
Sector
Healthcare
Industry
Medical - Equipment & Services
CEO
Daniel A. Carestio
View full financials